$8.18
-0.12-1.45%
Last update: Sep 20, 5:03 PM
15 minutes delayed
Tango Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tango Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.24 | $-0.34 | 29.4 % |
Mar 2024 | 2024-05-08 | $-0.35 | $-0.31 | -12.9 % |
Dec 2023 | 2024-03-18 | $-0.32 | $-0.28 | -14.3 % |
Sep 2023 | 2023-11-08 | $-0.23 | $-0.34 | 32.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $19.88M | $7.42M | 167.9 % |
Mar 2024 | 2024-05-08 | $6.47M | $6.67M | -2.98 % |
Dec 2023 | 2024-03-18 | $5.43M | $8.24M | -34.1 % |
Sep 2023 | 2023-11-08 | $10.73M | $7.32M | 46.6 % |
Tango Therapeutics (TNGX) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.24, which beat the estimate of $-0.34.
The Actual Revenue was $19.9M, which beat the estimate of $7.4M.
Browse earnings estimates, EPS, and revenue on all stocks.